QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.106054v1 jpet.106.106054v2 319/1/8    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prakash, J. Articles by Kok, R. J. Search for Related Content PubMed PubMed Citation Articles by Prakash, J. Articles by Kok, R. J.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Intracellular Delivery of the p38 Mitogen-Activated Protein Kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in Renal Tubular Cells: A Novel Strategy to Treat Renal Fibrosis

Departments of Pharmacokinetics and Drug Delivery (J.P., V.S., J.H.P., F.M., D.K.F.M, K.P., R.J.K.), Clinical Pharmacology (M.S., R.H.H.), and Pathology and Laboratory Medicine (M.H.d.B., H.v.G.), Groningen University Institute for Drug Exploration, Groningen, The Netherlands; Kreatech Biotechnology B.V., Amsterdam, The Netherlands (M.L., R.Q.J.S.); Vichem Chemie Research Ltd., Budapest, Hungary (G.K.); and Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands (R.J.K.)

During renal injury, activation of p38 mitogen-activated protein kinase (MAPK) in proximal tubular cells plays an important role in the inflammatory events that eventually lead to renal fibrosis. We hypothesized that local inhibition of p38 within these cells may be an interesting approach for the treatment of renal fibrosis. To effectuate this, we developed a renal-specific conjugate of the p38 inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] and the carrier lysozyme. First, we demonstrated that SB202190 inhibited the expression of albumin-induced proinflammatory (monocyte chemoattractant protein-1) and transforming growth factor (TGF)-1-induced profibrotic (procollagen-I1) genes over 50% in renal tubular cells (normal rat kidney-52E). Next, we conjugated SB202190 via a carbamate linkage to lysozyme. However, this conjugate rapidly released the drug upon incubation in serum. Therefore, we applied a new platinum(II)-based linker approach, the so-called universal linkage system (ULS), which forms a coordinative bond with SB202190. The SB202190-ULS-lysozyme remained stable in serum but released the drug in kidney homogenates. SB202190-ULS-lysozyme accumulated efficiently in renal tubular cells and provided a local drug reservoir during a period of 3 days after a single intravenous injection. Treatment with SB202190-ULS-lysozyme inhibited TGF-1-induced gene expression for procollagen-I1 by 64% in HK-2 cells. Lastly, we evaluated the efficacy of a single dose of the conjugate in the unilateral renal ischemia-reperfusion rat model. A reduction of intrarenal p38 phosphorylation and -smooth muscle actin protein expression was observed 4 days after the ischemia-reperfusion injury. In conclusion, we have developed a novel strategy for local delivery of the p38 MAPK inhibitor SB202190, which may be of use in the treatment of renal fibrosis.

Address correspondence to: Dr. Robbert J. Kock, Department of Pharmaceutics, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. E-mail: R.J.Kok{at}pharm.uu.nl

This article has been cited by other articles:

				P. Boor, K. Sebekova, T. Ostendorf, and J. Floege Treatment targets in renal fibrosis Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407. [Full Text] [PDF]

				T. Gonzalo, L. Beljaars, M. van de Bovenkamp, K. Temming, A.-M. van Loenen, C. Reker-Smit, D. K. F. Meijer, M. Lacombe, F. Opdam, G. Keri, et al. Local Inhibition of Liver Fibrosis by Specific Delivery of a Platelet-Derived Growth Factor Kinase Inhibitor to Hepatic Stellate Cells J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 856 - 865. [Abstract] [Full Text] [PDF]